ONCY - Oncolytics Biot Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (%) TVIX (%) TLRA (%) RKDA (-0.95%) PYPL (%) PG (0.64%) PFE (1.62%) NVS (0.01%) MSFT (%) MRK (1.46%) MCD (0.18%) JMIA (2.91%) IRBT (%) GOOGL (%) GE (%) FB (%) ETHUSD (%) EKSO (-1.15%) DIS (%) CVX (1.5%) CVNA (-2.19%) BTCUSD (%) BBY (1.29%) BAC (0.8%) AVB (1.08%)

Oncolytics Biotech(R) Announces Closing ...	08/16/19
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / August 16, 2019 / Oncolytics Biotech® Inc. (ONCY)(ONC.TO) (the “Company”), currently developing pelareore...

The Daily Biotech Pulse: Mallinkckrodt's...	08/15/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) ...

CORRECTION: Oncolytics Biotech(R) Announ...	08/14/19
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / August 14, 2019 / Oncolytics Biotech® Inc. (ONCY) (ONC.TO) (the “Company”), currently developing pelareor...

Oncolytics Biotech(R) Announces Pricing ...	08/14/19
SAN DIEGO, CA & CALGARY, AB / ACCESSWIRE / August 14, 2019 / Oncolytics Biotech® Inc. (ONCY) (ONC.TO) (the “Company”), currently developing pelareorep...

Oncolytics Biotech(R) Announces Public O...	08/13/19
SAN DIEGO, CA and CALGARY, AB, August 13, 2019 / Oncolytics Biotech® Inc. (ONCY) (TSX:ONC), currently developing pelareorep, an intravenously delivere...

Oncolytics Biotech(R) Reports 2019 Secon...	08/13/19
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / August 13, 2019 / Oncolytics Biotech® Inc. (ONCY)(TSX:ONC), currently developing pelareorep, an intraveno...

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$0.63	Open	$0.67
Volume	245.6K	Market Cap	35.93M
Yield		Last Dividend

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

ONCY - Oncolytics Biotech I...

$0.62 -0.01[%]

Add to New List:

Day

52 Week

ANALYST RATINGS

0.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $ONCY

About Us

Product Types

Strategies

Follow Us

Secure Payments